S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
5 Hypergrowth Stocks to Own in 2023 (Ad)pixel
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
NASDAQ:ZNTL

Zentalis Pharmaceuticals - ZNTL SEC Filings & 10K Form

$21.89
+0.80 (+3.79%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$20.38
$22.24
50-Day Range
$18.39
$25.60
52-Week Range
$17.33
$85.95
Volume
561,242 shs
Average Volume
603,791 shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$46.56

Recent Zentalis Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2022
6:50 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2022
6:07 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2022
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2022
7:38 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2022
4:24 PM
Zentalis Pharmaceuticals (Filer)
Form 10-K/A
10/17/2022
8:02 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2022
3:40 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
5:42 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
5:40 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
5:37 PM
Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
5:35 PM
Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2022
3:08 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2022
7:25 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2022
6:07 AM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2022
6:06 AM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2022
6:05 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2022
3:13 PM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2022
4:28 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2022
4:22 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2022
3:15 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2022
7:28 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2022
5:37 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2022
3:19 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
6:05 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2022
9:54 AM
GOEL DAVID E. (Reporting)
Matrix Capital Management Company, LP (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2022
9:52 AM
Matrix Capital Management Company, LP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13D
05/31/2022
3:06 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2022
3:03 PM
Zentalis Pharmaceuticals (Filer)
Form DEFA14A
05/31/2022
3:03 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2022
4:24 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
3:27 PM
Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2022
4:18 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2022
6:26 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2022
6:09 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2022
6:05 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2022
3:16 PM
Zentalis Pharmaceuticals (Filer)
Form DEFA14A
04/28/2022
3:12 PM
Zentalis Pharmaceuticals (Filer)
Form DEF 14A
04/27/2022
3:09 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2022
4:53 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
6:32 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
6:32 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
6:31 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
11:59 AM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
7:01 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
6:59 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
6:59 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
3:56 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
3:55 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
3:55 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
7:01 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
7:01 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
7:00 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
7:00 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
4:30 PM
Zentalis Pharmaceuticals (Filer)
Form 424B5
06/28/2021
6:11 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2021
4:27 PM
Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
4:26 PM
Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
4:22 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2021
7:27 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
7:26 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
7:26 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
7:26 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
6:06 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/17/2021
6:02 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
4:29 PM
Zentalis Pharmaceuticals (Filer)
Form S-3ASR
05/04/2021
11:37 AM
Zentalis Pharmaceuticals (Filer)
Form RW
04/14/2021
4:06 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:48 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:46 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:43 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:40 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
4:04 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2021
6:49 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2021
6:17 AM
Zentalis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2021
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2021
3:28 PM
Zentalis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/10/2021
7:26 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
5:03 AM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:37 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:05 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:04 PM
Pinto Alexis (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:02 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:02 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:01 PM
Voliotis Dimitris (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
6:01 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:30 PM
CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/10/2021
8:41 AM
Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
8:41 AM
Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/10/2021
8:37 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2021
9:35 AM
FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/03/2021
4:56 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:56 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:55 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:55 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:54 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4/A
02/03/2021
4:27 PM
SUN ANTHONY Y (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G
01/06/2021
7:25 PM
SUN ANTHONY Y (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:25 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:25 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:24 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:ZNTL) was last updated on 12/4/2022 by MarketBeat.com Staff